Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 62, Issue 11, Pages 1673-1685Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2013.07.007
Keywords
Obesity; Dyslipidemia; Hyperglycemia; Eicosanoids
Categories
Funding
- American Heart Association Scientist Development Grant [0930335N]
- Digestive Disease Research Center at Vanderbilt University [DK058404]
Ask authors/readers for more resources
Objective. Adipose tissue (AT)-specific inflammation is considered to mediate the pathological consequences of obesity and macrophages are known to activate inflammatory pathways in obese AT. Because cyclooxygenases play a central role in regulating the inflammatory processes, we sought to determine the role of hematopoietic cyclooxygenase-1 (COX-1) in modulating AT inflammation in obesity. Materials/Methods. Bone marrow transplantation was performed to delete COX-1 in hematopoietic cells. Briefly, female wild type (wt) mice were lethally irradiated and injected with bone marrow (BM) cells collected from wild type (COX-1+/+) or COX-1 knock-out (COX-1-/-) donor mice. The mice were fed a high fat diet for 16 weeks. Results. The mice that received COX-1-/- bone marrow (BM-COX-1-/-) exhibited a significant increase in fasting glucose, total cholesterol and triglycerides in the circulation compared to control (BM-COX-1+/+) mice. Markers of AT-inflammation were increased and were associated with increased leptin and decreased adiponectin in plasma. Hepatic inflammation was reduced with a concomitant reduction in TXB2 levels. The hepatic mRNA expression of genes involved in lipogenesis and lipid transport was increased while
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available